Achieve Life Sciences Announces Director, Officer Changes
Ticker: ACHV · Form: 8-K · Filed: Jan 10, 2025 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $40,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-structure, executive-compensation
Related Tickers: ACHV
TL;DR
Achieve Life Sciences is shuffling its board and execs, moving its HQ to Canada.
AI Summary
Achieve Life Sciences, Inc. announced on January 6, 2025, a series of significant corporate actions. These include the election of new directors, the appointment of certain officers, and updates to compensatory arrangements for its executives. The company also reported a change in its principal executive offices to Vancouver, BC, Canada.
Why It Matters
Changes in board composition and executive appointments can signal shifts in company strategy or operational focus, potentially impacting future performance and shareholder value.
Risk Assessment
Risk Level: medium — Changes in leadership and corporate structure can introduce uncertainty and potential execution risks.
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- January 6, 2025 (date) — Date of earliest event reported
- 22722 29th Drive SE , Suite 100 Bothell , WA 98021 (address) — Former principal executive offices
- 1040 West Georgia , Suite 1030 Vancouver , BC , Canada V6E 4H1 (address) — New principal executive offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but does not specify the names of newly elected or departing directors in the provided text.
Who were the newly appointed officers?
The filing mentions the appointment of certain officers, but the specific names and roles are not detailed in the provided excerpt.
What are the details of the updated compensatory arrangements?
The filing notes updates to compensatory arrangements for certain officers, but the specifics of these arrangements are not included in the provided text.
When did the company's principal executive offices change?
The change in principal executive offices to Vancouver, BC, Canada, is reported as of January 6, 2025.
What was the previous address of the company's principal executive offices?
The previous address for the principal executive offices was 22722 29th Drive SE, Suite 100, Bothell, WA 98021.
Filing Stats: 885 words · 4 min read · ~3 pages · Grade level 13.1 · Accepted 2025-01-10 09:26:43
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ACHV The Nasdaq Stock Mar
- $40,000 — f the Incoming Directors will receive a $40,000 annual retainer for service as a non-em
Filing Documents
- achv-20250106.htm (8-K) — 48KB
- 0000950170-25-003873.txt ( ) — 199KB
- achv-20250106.xsd (EX-101.SCH) — 50KB
- achv-20250106_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACHIEVE LIFE SCIENCES, INC. Date: January 10, 2025 /s/ Mark Oki Mark Oki Chief Financial Officer (Principal Financial Officer)